Recombinant Human Latent TGF-beta bp4 Protein, CF
Recombinant Human Latent TGF-beta bp4 Protein, CF Summary
Product Specifications
Met1-Ala1624, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
8068-LT
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 200 μg/mL in PBS. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: Latent TGF-beta bp4
Latent TGF‑ beta Binding Protein‑4 (LTBP‑4) is a widely expressed 170‑230 kDa secreted glycoprotein within the LTBP/fibrillin family (1‑3). LTBPs contain a conserved pattern of eight-cysteine motifs (8Cys) and EGF‑like (EGFL) domains (2‑4). The 1624 amino acid (aa) human LTBP‑4 (L isoform) includes a signal sequence (aa 1‑27), a heparin-binding N‑terminal domain (aa 28‑460) with two EGFL, one hybrid and one 8‑Cys motif, a protease-sensitive hinge region, a central region with 10 EGFL motifs, and a C‑terminal domain (aa 1180‑1624) with two EGFL and two 8Cys (1‑4). The first C‑terminal 8Cys motif is responsible for covalent association with the latency associated peptide (LAP) of latent TGF‑ beta 1 (1‑4). Unlike LTBP-1 and ‑3, LTBP‑4 does not bind TGF‑ beta 2 or TGF‑ beta 3 LAPs (4). LTBP‑4 also binds fibronectin, which mediates targeting to extracellular matrix (ECM), fibrillin-1 which mediates binding to microfibrils, and the cytokine midkine (1, 5, 6). Mature human LTBP‑4 (LTBP‑4L) shares 87% and 90% aa sequence identity with mouse and rat LTBP‑4, respectively. A variant that lacks the TGF‑binding 8Cys motif is reported to be widely expressed along with LTBP‑4L (3). Other differentially expressed human splice isoforms of 1557 (LTBP‑4S), 1587 and 636 aa have alternate N‑termini through aa 69, 151, and 919 (also lacking aa 1005‑1090), respectively (1, 7). LTBP‑4 is involved in the assembly, secretion and targeting of latent TGF‑ beta 1 to sites where it can be activated. Deletion or mutation in humans can cause Urban‑Rifkin‑Davis syndrome (URDS), a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal and dermal development mediated by enhanced TGF‑ beta 1 activity (8). Similar defects are found in mice deleted for LTBP‑4 (9‑11). Impaired LTBP‑4 expression enhances susceptibility to colon cancer (8). LTBP-4 is also down‑regulated in breast cancer tissues (5).
- Kantola, A.K. et al. (2008) Exp. Cell Res. 314:2488.
- Saharinen, J. et al. (1998) J. Biol. Chem. 273:18459.
- Koli, K. et al. (2001) J. Cell Sci. 114:2869.
- Saharinen, J. and J. Keski-Oja (2000) Mol. Biol. Cell 11:2691.
- Takahashi, Y. et al. (2012) Breast Cancer 19:46.
- Yan, Q. et al. (2012) Hepatobiliary Pancreat. Dis. Int. 11:272.
- Kantola, A.K. et al. (2010) J. Cell Physiol. 223:727.
- Urban, Z. et al. (2009) Am. J. Hum. Genet. 85:593.
- Sterner-Kock, A. et al. (2002) Genes Dev. 16:2264.
- Dabovic, B. et al. (2009) J. Cell Physiol. 219:14.
- Koli, K. et al. (2004) J. Cell Biol. 167:123.
Citation for Recombinant Human Latent TGF-beta bp4 Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Rational correction of pathogenic conformational defects in HTRA1
Authors: Beaufort, N;Ingendahl, L;Merdanovic, M;Schmidt, A;Podlesainski, D;Richter, T;Neumann, T;Kuszner, M;Vetter, IR;Stege, P;Burston, SG;Filipovic, A;Ruiz-Blanco, YB;Bravo-Rodriguez, K;Mieres-Perez, J;Beuck, C;Uebel, S;Zobawa, M;Schillinger, J;Malik, R;Todorov-Völgyi, K;Rey, J;Roberti, A;Hagemeier, B;Wefers, B;Müller, SA;Wurst, W;Sanchez-Garcia, E;Zimmermann, A;Hu, XY;Clausen, T;Huber, R;Lichtenthaler, SF;Schmuck, C;Giese, M;Kaiser, M;Ehrmann, M;Dichgans, M;
Nature communications
Species: N/A
Sample Types: Recombinant Protein
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Latent TGF-beta bp4 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Latent TGF-beta bp4 Protein, CF and earn rewards!
Have you used Recombinant Human Latent TGF-beta bp4 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
